PT -期刊文章AU -奈尔Fotedar盟Hemani Ticku AU - Vishakhadatta Mathur Kumaraswamy盟马克·科恩-丹尼尔·米勒盟盟-迈克尔·摩根盟Komal Sawlani TI -免疫抑制剂检查站后眼部症状。(p3.4 - 013) DP - 2019年4月09年TA -神首页经病学第六PG - p3.4 - 013 - 92 IP - 15补充4099 - //www.ez-admanager.com/content/92/15_supplement/p3.4 013. - 013.短4100 - //www.ez-admanager.com/content/92/15_supplement/p3.4 - -全所以Neurology2019 4月09年;92 AB -目的:报告一例系列4病人并回顾相关的文献对神经肌肉的几种不良事件(ira)的免疫抑制剂检查站(ICPis),特别是眼部弱点参与和开发一个接近这些病人的诊断算法。背景:ICPis癌症治疗使用的不断增加导致了爱尔兰共和军的广泛的认可,包括神经肌肉疾病。而神经肌肉接点(NMJ)障碍与眼部症状,通常被认为是肌炎、眼外肌肉转移,脱髓鞘疾病也应该差。测试为管理这些方案势在必行。设计/方法:回顾四眼患者的弱点,发达之后收到ICPisResults:所有四个患者接受ICPis和发达眼部症状。四分之三的患者也有呼吸困难、吞咽困难或近端无力。患者1的检查显示高乙酰胆碱受体抗体(乙酰胆碱受体)和CK水平升高。上直肌肌肉的尸检,活检显示肌炎。因此,神经肌肉软弱是次要irMyositis和可能的NMJ障碍。 Patient 2’s work-up showed negative AChR antibody testing, elevated CK level, myopathic motor units on EMG, and triceps muscle biopsy showed myositis; thus, neuromuscular weakness was secondary to irMyositis. Patient 3’s work-up showed mildly elevated CK level, positive AChR antibodies, and EMG evidence of a demyelinating neuropathy. Deltoid muscle biopsy showed myositis; thus neuromuscular weakness was secondary to irMyositis, irDemyelinating neuropathy and possible irNMJ disorder. Patient 4 presented with diplopia only with normal CK level and negative AChR antibody testing. MRI Orbit revealed evidence of a metastasis to the left superior oblique muscle.Conclusions: Ocular symptoms following ICPi therapy does not always represent a neuromuscular junction disorder. It is important to include myositis, demyelinating neuropathies, and orbital metastases to the differential because the natural history and management are variable.Disclosure: Dr. Fotedar has nothing to disclose. Dr. Ticku has nothing to disclose. Dr. Mathur Kumaraswamy has nothing to disclose. Dr. Miller has nothing to disclose. Dr. Cohen has nothing to disclose. Dr. Morgan has nothing to disclose. Dr. Sawlani has nothing to disclose.

map